Panel rules against Canada on patent terms for pre-TRIPS patents.
On 5 May 2000, the WTO Panel issued another ruling regarding patents of relevance to pharmaceutical products. Upholding a complaint by the US, the Panel ruled that Canada's Patent Act was in breach of the minimum patent terms for inventions required by the Agreement on Trade-Related Aspects of Intellectual Property Rights (the TRIPS Agreement).